Siren, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002005245

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 116 positions · Total reported value $4.93B · Top-10 concentration 44.8% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.7% · 15 new · 36 cut · 22 exited

Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Siren, L.L.C. disclosed 116 equity positions with a combined reported value of $4.93B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were SRRK ($526.63M), KYMR ($336.65M), ERAS ($208.81M). By sector, the heaviest allocations are Health Care 92.0%, Technology 4.5%. Versus the prior quarter, allocation shifted toward Health Care (+1.6pp), Financials (+0.8pp) and away from Other (-2.0pp).

Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q2 2026 were PBLS ($81.90M), ABVX ($76.76M), COAG ($76.65M).

Of the 22 positions fully exited versus the prior quarter, the largest were CNTA ($41.84M), FULC ($18.02M), WVE ($17.76M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • PBLS Parabilis Medicines Inc · $81.90M
  • ABVX Abivax SA · $76.76M
  • COAG Hemab Therapeutics Holdings Inc · $76.65M
  • RLAY Relay Therapeutics, Inc. · $68.29M
  • KLRA Kailera Therapeutics Inc · $48.78M
  • COF CAPITAL ONE FINL CORP · $34.43M
  • ORKA ORUKA THERAPEUTICS INC · $23.79M
  • SPTX Seaport Therapeutics Inc · $23.79M

Fully Exited (vs previous quarter)

  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $41.84M
  • FULC FULCRUM THERAPEUTICS INC COM · prev qtr: $18.02M
  • WVE WAVE LIFE SCIENCES INC · prev qtr: $17.76M
  • QURE UNIQURE NV · prev qtr: $16.35M
  • BCYC BICYCLE THERAPEUTICS PLC · prev qtr: $7.24M
  • FPS FORGENT POWER SOLUTIONS INC · prev qtr: $2.93M
  • MU MICRON TECHNOLOGY INC · prev qtr: $2.03M
  • AS Amer Sports Inc · prev qtr: $1.65M

Insider Transactions (Form 4)

Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).

Portfolio Structure

  • 116 positions · $4.93B reported value (Q2 2026)
  • Top 10 holdings = 44.8% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
  • Average position size: $42.48M

Sector Tilt

  • Health Care 92.0%
  • Information Technology 4.5%
  • Consumer Discretionary 1.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.0%
Technology 4.5%
Financials 0.9%
Other 1.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.58M $526.63M 10.69%
10.69%
Reduce
2 2.94M $336.65M 6.83%
6.83%
Reduce
3 11.40M $208.81M 4.24%
4.24%
Add
4 1.66M $203.51M 4.13%
4.13%
Add
5 6.18M $193.17M 3.92%
3.92%
Add
6 900.00K $168.55M 3.42%
3.42%
Reduce
7 5.60M $166.35M 3.38%
3.38%
Reduce
8 1.72M $139.83M 2.84%
2.84%
Add
9 465.00K $132.51M 2.69%
2.69%
Hold
10 3.18M $129.39M 2.63%
2.63%
Reduce
11 1.14M $126.16M 2.56%
2.56%
Add
12 44.30M $106.33M 2.16%
2.16%
Hold
13 1.77M $90.05M 1.83%
1.83%
Add
14 968.60K $85.99M 1.75%
1.75%
Add
15 2.99M $81.90M 1.66%
1.66%
New
16 1.32M $79.59M 1.61%
1.61%
Hold
17 7.69M $76.83M 1.56%
1.56%
Hold
18 576.00K $76.76M 1.56%
1.56%
New
19 2.09M $76.65M 1.56%
1.56%
New
20 2.42M $74.62M 1.51%
1.51%
Reduce
21 1.86M $71.95M 1.46%
1.46%
Add
22 3.65M $68.29M 1.39%
1.39%
New
23 9.85M $67.06M 1.36%
1.36%
Add
24 1.42M $66.77M 1.35%
1.35%
Add
25 2.00M $65.29M 1.32%
1.32%
Hold
26 888.40K $64.98M 1.32%
1.32%
Reduce
27 758.95K $64.66M 1.31%
1.31%
Add
28 1.90M $63.63M 1.29%
1.29%
Reduce
29 4.86M $60.76M 1.23%
1.23%
Add
30 1.42M $53.17M 1.08%
1.08%
Reduce
31 2.21M $48.78M 0.99%
0.99%
New
32 2.13M $47.29M 0.96%
0.96%
Reduce
33 872.97K $46.85M 0.95%
0.95%
Reduce
34 8.42M $42.12M 0.85%
0.85%
Reduce
35 257.49K $39.35M 0.80%
0.80%
Hold
36 3.31M $36.36M 0.74%
0.74%
Add
37 1.40M $35.92M 0.73%
0.73%
Hold
38 1.54M $34.58M 0.70%
0.70%
Hold
39 1.89M $34.48M 0.70%
0.70%
Add
40 171.62K $34.43M 0.70%
0.70%
New
41 1.79M $33.33M 0.68%
0.68%
Hold
42 3.00M $32.47M 0.66%
0.66%
Hold
43 90.00K $32.16M 0.65%
0.65%
Add
44 1.86M $30.46M 0.62%
0.62%
Hold
45 2.47M $28.68M 0.58%
0.58%
Add
46 610.51K $26.86M 0.55%
0.55%
Add
47 641.47K $26.73M 0.54%
0.54%
Hold
48 1.48M $26.59M 0.54%
0.54%
Add
49 4.46M $25.46M 0.52%
0.52%
Add
50 270.12K $25.01M 0.51%
0.51%
Hold

FAQ

What did Siren, L.L.C. buy in 2026-Q2?

In its 2026-Q2 13F filing, Siren, L.L.C. reported 116 equity positions worth $4.93B in aggregate; its largest disclosed positions were SRRK ($526.63M), KYMR ($336.65M), ERAS ($208.81M).

How large is Siren, L.L.C.'s portfolio?

Siren, L.L.C. reported $4.93B of long equity holdings across 116 positions as of 2026-Q2. Top-10 holdings account for 44.8% of reported value.

What is Siren, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/siren/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →